참고문헌
- Brakenhielm E, Veitonmaki N, Cao R, et al (2004). Adiponectininduced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A, 101, 2476-81. https://doi.org/10.1073/pnas.0308671100
- Cauley JA, Gutai JP, Kuller LH, et al (1989). The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol, 129, 1120-31.
- Chen DC, Chung YF, Yeh YT, et al (2006). Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett, 237, 109-14. https://doi.org/10.1016/j.canlet.2005.05.047
- Cleary MP, Maihle NJ (1997). The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med, 216, 28-43. https://doi.org/10.3181/00379727-216-44153B
- Cust AE, Stocks T, Lukanova A, et al (2009). The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat, 113, 567-76. https://doi.org/10.1007/s10549-008-9958-8
- Dieudonne MN, Bussiere M, Dos Santos E, et al (2006). Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 345, 271-9. https://doi.org/10.1016/j.bbrc.2006.04.076
- Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, et al (2002). Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 293, 622-8. https://doi.org/10.1016/S0006-291X(02)00205-X
- Fisher FM, Trujillo ME, Hanif W, et al (2005). Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia, 48, 1084-7. https://doi.org/10.1007/s00125-005-1758-7
- Fontana L, Eagon JC, Trujillo ME, et al (2007). Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes, 56, 1010-3. https://doi.org/10.2337/db06-1656
- Frankenberry KA, Skinner H, Somasundar P, et al (2006). Leptin receptor expression and cell signaling in breast cancer. Int J Oncol, 28, 985-93.
- Gadgil A, Roy N, Sankaranarayanan R, et al (2012). Effect of comprehensive breast care on breast cancer outcomes: a community hospital based study from Mumbai, India. Asian Pac J Cancer Prev, 13, 1105-9. https://doi.org/10.7314/APJCP.2012.13.4.1105
- Gaudet MM, Falk RT, Gierach GL, et al (2010). Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol, 34, 580-6. https://doi.org/10.1016/j.canep.2010.05.014
- Goodwin PJ, Ennis M, Fantus IG, et al (2005). Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol, 23, 6037-42. https://doi.org/10.1200/JCO.2005.02.048
- Gross AL, Newschaffer CJ, Hoffman-Bolton J, et al (2013). Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev, 22, 1319-24. https://doi.org/10.1158/1055-9965.EPI-12-1444
- Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev, 13, 395-8. https://doi.org/10.7314/APJCP.2012.13.1.395
- Haghighat S, Akbari ME, Ghaffari S, et al (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8. https://doi.org/10.7314/APJCP.2012.13.11.5525
- Harris HR, Tworoger SS, Hankinson SE, et al (2011). Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res, 4, 1449-56. https://doi.org/10.1158/1940-6207.CAPR-11-0125
- Hou WK, Xu YX, Yu T, et al (2007). Adipocytokines and breast cancer risk. Chin Med J, 120, 1592-6.
- Hu X, Juneja SC, Maihle NJ, et al (2002). Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst, 94, 1704-11. https://doi.org/10.1093/jnci/94.22.1704
- Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, et al (2009). Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer, 16, 1197-210. https://doi.org/10.1677/ERC-09-0043
- Karimi N, Roshan VD (2013). Change in adiponectin and oxidative stress after modifiable lifestyle interventions in breast cancer cases. Asian Pac J Cancer Prev, 14, 2845-50. https://doi.org/10.7314/APJCP.2013.14.5.2845
- Lee JJ, Park HY (2009). The timing of recurrence dependent on menopausal status after surgery for breast cancer. J Korean Surg Soc, 77, 75-81. https://doi.org/10.4174/jkss.2009.77.2.75
- Llanos AA, Dumitrescu RG, Marian C, et al (2012). Adipokines in plasma and breast tissues: associations with breast cancer risk factors. Cancer Epidemiol Biomarkers Prev, 21, 1745-55. https://doi.org/10.1158/1055-9965.EPI-12-0016
- Loi S, Milne RL, Friedlander ML, et al (2005). Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 14, 1686-91. https://doi.org/10.1158/1055-9965.EPI-05-0042
- Maccio A, Madeddu C (2011). Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. ScientificWorldJournal, 11, 2020-36. https://doi.org/10.1100/2011/806787
- Mantzoros C, Petridou E, Dessypris N, et al (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89, 1102-7. https://doi.org/10.1210/jc.2003-031804
- Mantzoros CS, Bolhke K, Moschos S, et al (1999). Leptin in relation to carcinoma in situ of the breast: a study of premenopausal cases and controls. Int J Cancer, 80, 523-6. https://doi.org/10.1002/(SICI)1097-0215(19990209)80:4<523::AID-IJC7>3.0.CO;2-C
- McTiernan A (2005). Obesity and cancer: the risks, science, and potential management strategies. Oncology, 19, 871-81.
- Miyoshi Y, Funahashi T, Kihara S, et al (2003). Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 9, 5699-704.
- Nkhata KJ, Ray A, Schuster TF, et al (2009). Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep, 21, 1611-9.
- Oh SW, Park CY, Lee ES, et al (2011). Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res, 13, 34.
- Ollberding NJ, Kim Y, Shvetsov YB, et al (2013). Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer. Cancer Prev Res (Phila), 6, 188-95. https://doi.org/10.1158/1940-6207.CAPR-12-0374
- Pajvani UB, Hawkins M, Combs TP, et al (2004). Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem, 279, 12152-62. https://doi.org/10.1074/jbc.M311113200
- Petridou E, Papadiamantis Y, Markopoulos C, et al (2000). Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control, 11, 383-8. https://doi.org/10.1023/A:1008903727238
- Porter GA, Inglis KM, Wood LA, et al (2006). Effect of obesity on presentation of breast cancer. Ann Surg Oncol, 13, 327-32. https://doi.org/10.1245/ASO.2006.03.049
- Ray A, Nkhata KJ, Cleary MP (2007). Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol, 30, 1499-509.
- Rock CL, Flatt SW, Laughlin GA, et al (2008). Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev, 17, 614-20. https://doi.org/10.1158/1055-9965.EPI-07-0761
- Stattin P, Soderberg S, Biessy C, et al (2004). Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat, 86, 191-6. https://doi.org/10.1023/B:BREA.0000036782.11945.d7
- Stuckey A (2011). Breast cancer: epidemiology and risk factors. Clin Obstet Gynecol, 54, 96-102. https://doi.org/10.1097/GRF.0b013e3182080056
- Sung H, Choi JY, Lee SA, et al (2012). The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer. BMC Cancer, 12, 193. https://doi.org/10.1186/1471-2407-12-193
- Sweeney C, Blair CK, Anderson KE, et al (2004). Risk factors for breast cancer in elderly women. Am J Epidemiol, 160, 868-75. https://doi.org/10.1093/aje/kwh276
- Tworoger SS, Eliassen AH, Kelesidis T, et al (2007). Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab, 92, 1510-16. https://doi.org/10.1210/jc.2006-1975
- Vona-Davis L, Rose DP (2007). Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer, 14, 189-206. https://doi.org/10.1677/ERC-06-0068
- Waki H, Yamauchi T, Kamon J, et al (2003). Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem, 278, 40352-63. https://doi.org/10.1074/jbc.M300365200
- Wu MH, Chou YC, Chou WY, et al (2009). Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer, 100, 578-82. https://doi.org/10.1038/sj.bjc.6604913
피인용 문헌
- Adiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis vol.14, pp.1, 2015, https://doi.org/10.1186/s12944-015-0157-4
- Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis vol.7, pp.3, 2015, https://doi.org/10.3390/cancers7030827
- Association of serum adiponectin with breast cancer vol.98, pp.6, 2019, https://doi.org/10.1097/MD.0000000000014359